Hong Kong · Delayed Price · Currency is HKD Yonghe Medical Group Statistics
Total Valuation
HKG:2279 has a market cap or net worth of HKD 1.09 billion. The enterprise value is 574.77 million.
| Market Cap | 1.09B |
| Enterprise Value | 574.77M |
Important Dates
The last earnings date was Thursday, August 20, 2026.
| Earnings Date | Aug 20, 2026 |
| Ex-Dividend Date | May 26, 2026 |
Share Statistics
HKG:2279 has 500.11 million shares outstanding. The number of shares has decreased by -0.67% in one year.
| Current Share Class | 500.11M |
| Shares Outstanding | 500.11M |
| Shares Change (YoY) | -0.67% |
| Shares Change (QoQ) | +0.01% |
| Owned by Insiders (%) | 41.44% |
| Owned by Institutions (%) | 0.03% |
| Float | 109.11M |
Valuation Ratios
The trailing PE ratio is 7.89 and the forward PE ratio is 8.06.
| PE Ratio | 7.89 |
| Forward PE | 8.06 |
| PS Ratio | 0.49 |
| PB Ratio | 1.15 |
| P/TBV Ratio | 1.18 |
| P/FCF Ratio | 1.80 |
| P/OCF Ratio | 1.72 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 1.21, with an EV/FCF ratio of 0.94.
| EV / Earnings | 4.10 |
| EV / Sales | 0.26 |
| EV / EBITDA | 1.21 |
| EV / EBIT | 2.72 |
| EV / FCF | 0.94 |
Financial Position
The company has a current ratio of 1.63, with a Debt / Equity ratio of 0.53.
| Current Ratio | 1.63 |
| Quick Ratio | 1.48 |
| Debt / Equity | 0.53 |
| Debt / EBITDA | 1.06 |
| Debt / FCF | 0.83 |
| Interest Coverage | 8.54 |
Financial Efficiency
Return on equity (ROE) is 15.47% and return on invested capital (ROIC) is 35.65%.
| Return on Equity (ROE) | 15.47% |
| Return on Assets (ROA) | 6.84% |
| Return on Invested Capital (ROIC) | 35.65% |
| Return on Capital Employed (ROCE) | 16.14% |
| Weighted Average Cost of Capital (WACC) | 6.22% |
| Revenue Per Employee | 614,005 |
| Profits Per Employee | 38,648 |
| Employee Count | 3,624 |
| Asset Turnover | 1.15 |
| Inventory Turnover | 29.32 |
Taxes
In the past 12 months, HKG:2279 has paid 51.09 million in taxes.
| Income Tax | 51.09M |
| Effective Tax Rate | 26.75% |
Stock Price Statistics
The stock price has decreased by -25.17% in the last 52 weeks. The beta is 0.58, so HKG:2279's price volatility has been lower than the market average.
| Beta (5Y) | 0.58 |
| 52-Week Price Change | -25.17% |
| 50-Day Moving Average | 2.24 |
| 200-Day Moving Average | 1.99 |
| Relative Strength Index (RSI) | 40.28 |
| Average Volume (20 Days) | 163,375 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKG:2279 had revenue of HKD 2.23 billion and earned 140.06 million in profits. Earnings per share was 0.28.
| Revenue | 2.23B |
| Gross Profit | 1.52B |
| Operating Income | 211.70M |
| Pretax Income | 190.97M |
| Net Income | 140.06M |
| EBITDA | 332.33M |
| EBIT | 211.70M |
| Earnings Per Share (EPS) | 0.28 |
Balance Sheet
The company has 1.02 billion in cash and 502.93 million in debt, with a net cash position of 517.12 million or 1.03 per share.
| Cash & Cash Equivalents | 1.02B |
| Total Debt | 502.93M |
| Net Cash | 517.12M |
| Net Cash Per Share | 1.03 |
| Equity (Book Value) | 952.11M |
| Book Value Per Share | 1.91 |
| Working Capital | 435.14M |
Cash Flow
In the last 12 months, operating cash flow was 635.86 million and capital expenditures -27.48 million, giving a free cash flow of 608.38 million.
| Operating Cash Flow | 635.86M |
| Capital Expenditures | -27.48M |
| Depreciation & Amortization | 121.90M |
| Net Borrowing | -250.62M |
| Free Cash Flow | 608.38M |
| FCF Per Share | 1.22 |
Margins
Gross margin is 68.53%, with operating and profit margins of 9.51% and 6.29%.
| Gross Margin | 68.53% |
| Operating Margin | 9.51% |
| Pretax Margin | 8.58% |
| Profit Margin | 6.29% |
| EBITDA Margin | 14.94% |
| EBIT Margin | 9.51% |
| FCF Margin | 27.06% |
Dividends & Yields
This stock pays an annual dividend of 0.09, which amounts to a dividend yield of 3.51%.
| Dividend Per Share | 0.09 |
| Dividend Yield | 3.51% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.67% |
| Shareholder Yield | 4.18% |
| Earnings Yield | 12.82% |
| FCF Yield | 55.67% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
HKG:2279 has an Altman Z-Score of 1.99 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.99 |
| Piotroski F-Score | 7 |